Lumos Pharma Inc (LUMO)
4.33
+0.01
(+0.23%)
USD |
NASDAQ |
Nov 21, 16:00
4.33
0.00 (0.00%)
After-Hours: 20:00
Lumos Pharma Price to Book Value: 7.621 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 7.621 |
November 20, 2024 | 7.603 |
November 19, 2024 | 7.621 |
November 18, 2024 | 7.603 |
November 15, 2024 | 7.621 |
November 14, 2024 | 7.621 |
November 13, 2024 | 7.568 |
November 12, 2024 | 7.674 |
November 11, 2024 | 7.691 |
November 08, 2024 | 7.672 |
November 07, 2024 | 7.612 |
November 06, 2024 | 7.586 |
November 05, 2024 | 7.726 |
November 04, 2024 | 7.77 |
November 01, 2024 | 7.691 |
October 31, 2024 | 7.814 |
October 30, 2024 | 7.638 |
October 29, 2024 | 7.691 |
October 28, 2024 | 7.832 |
October 25, 2024 | 7.744 |
October 24, 2024 | 7.656 |
October 23, 2024 | 7.673 |
October 22, 2024 | 6.952 |
October 21, 2024 | 6.565 |
October 18, 2024 | 7.075 |
Date | Value |
---|---|
October 17, 2024 | 6.652 |
October 16, 2024 | 7.057 |
October 15, 2024 | 7.022 |
October 14, 2024 | 6.864 |
October 11, 2024 | 6.670 |
October 10, 2024 | 6.781 |
October 09, 2024 | 6.547 |
October 08, 2024 | 6.776 |
October 07, 2024 | 6.793 |
October 04, 2024 | 6.230 |
October 03, 2024 | 6.424 |
October 02, 2024 | 6.459 |
October 01, 2024 | 6.318 |
September 30, 2024 | 6.811 |
September 27, 2024 | 3.115 |
September 26, 2024 | 3.036 |
September 25, 2024 | 3.202 |
September 24, 2024 | 3.099 |
September 23, 2024 | 2.973 |
September 20, 2024 | 3.107 |
September 19, 2024 | 3.099 |
September 18, 2024 | 2.925 |
September 17, 2024 | 3.068 |
September 16, 2024 | 3.060 |
September 13, 2024 | 3.107 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3773
Minimum
Dec 12 2022
7.832
Maximum
Oct 28 2024
1.130
Average
0.882
Median
Price to Book Value Benchmarks
Boston Scientific Corp | 6.512 |
Calidi Biotherapeutics Inc | -- |
NovaBay Pharmaceuticals Inc | 3.299 |
Palatin Technologies Inc | -- |
iBio Inc | 1.263 |
Price to Book Value Related Metrics
PS Ratio | 16.02 |
PEG Ratio | -0.1392 |
Price | 4.33 |
Earnings Yield | -99.08% |
Market Cap | 37.45M |
PEGY Ratio | -0.1392 |